Quotidiano Nazionale logo
Quotidiano Nazionale logo
il Giorno logo
4 dic 2020
4 dic 2020

Covid, il seminterrato del Niguarda pronto ad accogliere migliaia di vaccini

Due frigoriferi speciali conserveranno le dosi del prodotto sviluppato da Pfizer/Biontech

4 dic 2020
epa08590645 View of two vials with vaccine samples, in the laboratory of BioManguinhos, the institute for the production of immunobiologicals of the Oswaldo Cruz Foundation, in Rio de Janeiro, Brazil, 07 August 2020. Brazil, one of the countries in which the vaccine against the novel coronavirus developed by the British University of Oxford is being tested, expects to begin mass production of it in December, the state laboratory responsible reported on 07 August. BioManguinhos will also receive, in all its phases, the technology for the production in Rio de Janeiro of the vaccine starting next year.  EPA/Antonio Lacerda
Vaccino anti-Covid (Ansa)
epa08590645 View of two vials with vaccine samples, in the laboratory of BioManguinhos, the institute for the production of immunobiologicals of the Oswaldo Cruz Foundation, in Rio de Janeiro, Brazil, 07 August 2020. Brazil, one of the countries in which the vaccine against the novel coronavirus developed by the British University of Oxford is being tested, expects to begin mass production of it in December, the state laboratory responsible reported on 07 August. BioManguinhos will also receive, in all its phases, the technology for the production in Rio de Janeiro of the vaccine starting next year.  EPA/Antonio Lacerda
Vaccino anti-Covid (Ansa)

© Riproduzione riservata

Iscriviti alla newsletter.

Il modo più facile per rimanere sempre aggiornati

Hai già un account?